Science
Mechanism of Action
This advanced single-chain recombinant fusion peptide is synthesized via E. coli fermentation, combining the genetic sequences of sh-Polypeptide-76 and Decapeptide-40, initiated with methionine. Its action involves signaling the skin's intrinsic repair mechanisms, contributing to antioxidant defense and promoting an improved epidermal condition. Related peptides are known to enhance extracellular matrix protein synthesis and epidermal lipid production, thereby bolstering skin integrity and protective function, suggesting a similar functional pathway for this fusion peptide.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
This ingredient is recognized in the European Commission's CosIng database as an antioxidant. However, specific safety assessments by SCCS, CIR, or FDA for this precise fusion peptide are not publicly available at present.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting a promising mechanism for skin conditioning and antioxidant support based on related peptide research, specific clinical efficacy data for Methionyl sh-Polypeptide-76 Decapeptide-40 is currently insufficient for a definitive rating.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources